Imago BioSciences (IMGO)
US Market

Imago BioSciences (IMGO) Stock Price & Analysis


IMGO Stock Chart & Stats

Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding33,841,229
10 Day Avg. Volume0
30 Day Avg. Volume244,029
Standard Deviation0.33
Financial Highlights & Ratios
Price to Book (P/B)7.06
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-31.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Imago BioSciences’s price range in the past 12 months?
Currently, no data Available
What is Imago BioSciences’s market cap?
Currently, no data Available
When is Imago BioSciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Imago BioSciences’s earnings last quarter?
Currently, no data Available
Is Imago BioSciences overvalued?
According to Wall Street analysts Imago BioSciences’s price is currently same. Get more investment ideas with TipRanks Premium
    Does Imago BioSciences pay dividends?
    Imago BioSciences does not currently pay dividends.
    What is Imago BioSciences’s EPS estimate?
    Imago BioSciences’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Imago BioSciences have?
    Currently, no data Available
    What happened to Imago BioSciences’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Imago BioSciences?
    Among the largest hedge funds holding Imago BioSciences’s share is Omega Fund Management, LLC. It holds Imago BioSciences’s shares valued at 109M.


      Imago BioSciences Stock Smart Score

      The Imago BioSciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
      Learn more about TipRanks Smart Score

      Company Description

      Imago BioSciences

      Imago BioSciences Inc is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. It is focused on improving the quality and length of life for patients with cancer and bone marrow diseases. Bomedemstat, an orally available, small molecule inhibitor of LSD1, is the product candidate discovered by Imago for the treatment of certain myeloproliferative neoplasms (MPNs), a family of related, chronic cancers of the bone marrow. Imago is evaluating Bomedemstat as a potentially disease-modifying therapy in two Phase 2 clinical trials for the treatment of essential thrombocythemia (ET) and myelofibrosis (MF).


      Forecast EPS vs Actual EPS

      Currently, no data available
      Please return soon. This page is being updated.

      Similar Stocks
      Price & Change
      Keros Therapeutics
      BridgeBio Pharma
      Travere Therapeutics
      Chinook Therapeutics

      Popular Stocks

      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis